Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
letter
. 1995 Dec;57(6):1505–1508.

Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI.

B Steinmann, D R Eyre, P Shao
PMCID: PMC1801424  PMID: 8533783

Full text

PDF
1507

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beardsworth L. J., Eyre D. R., Dickson I. R. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res. 1990 Jul;5(7):671–676. doi: 10.1002/jbmr.5650050702. [DOI] [PubMed] [Google Scholar]
  2. Bollen A. M., Eyre D. R. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone. 1994 Jan-Feb;15(1):31–34. doi: 10.1016/8756-3282(94)90888-5. [DOI] [PubMed] [Google Scholar]
  3. Eyre D. Collagen cross-linking amino acids. Methods Enzymol. 1987;144:115–139. doi: 10.1016/0076-6879(87)44176-1. [DOI] [PubMed] [Google Scholar]
  4. Garnero P., Shih W. J., Gineyts E., Karpf D. B., Delmas P. D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 1994 Dec;79(6):1693–1700. doi: 10.1210/jcem.79.6.7989477. [DOI] [PubMed] [Google Scholar]
  5. Gerriets J. E., Curwin S. L., Last J. A. Tendon hypertrophy is associated with increased hydroxylation of nonhelical lysine residues at two specific cross-linking sites in type I collagen. J Biol Chem. 1993 Dec 5;268(34):25553–25560. [PubMed] [Google Scholar]
  6. Hanson D. A., Weis M. A., Bollen A. M., Maslan S. L., Singer F. R., Eyre D. R. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 1992 Nov;7(11):1251–1258. doi: 10.1002/jbmr.5650071119. [DOI] [PubMed] [Google Scholar]
  7. Hautala T., Heikkinen J., Kivirikko K. I., Myllylä R. A large duplication in the gene for lysyl hydroxylase accounts for the type VI variant of Ehlers-Danlos syndrome in two siblings. Genomics. 1993 Feb;15(2):399–404. doi: 10.1006/geno.1993.1074. [DOI] [PubMed] [Google Scholar]
  8. Hyland J., Ala-Kokko L., Royce P., Steinmann B., Kivirikko K. I., Myllylä R. A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI. Nat Genet. 1992 Nov;2(3):228–231. doi: 10.1038/ng1192-228. [DOI] [PubMed] [Google Scholar]
  9. Pasquali M., Dembure P. P., Still M. J., Elsas L. J. Urinary pyridinium cross-links: a noninvasive diagnostic test for Ehlers-Danlos syndrome type VI. N Engl J Med. 1994 Jul 14;331(2):132–133. doi: 10.1056/NEJM199407143310217. [DOI] [PubMed] [Google Scholar]
  10. Robins S. P., Black D., Paterson C. R., Reid D. M., Duncan A., Seibel M. J. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest. 1991 Jun;21(3):310–315. doi: 10.1111/j.1365-2362.1991.tb01375.x. [DOI] [PubMed] [Google Scholar]
  11. Royce P. M., Barnes M. J. Failure of highly purified lysyl hydroxylase to hydroxylate lysyl residues in the non-helical regions of collagen. Biochem J. 1985 Sep 1;230(2):475–480. doi: 10.1042/bj2300475. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES